We are joined by Athena Sofides who co-wrote (with Ed) a brilliant essay in The Baffler, which provides an in-depth analysis of insulin, the social health factors of diabetes, and the global oligopoly of pharmaceutical corporations that exert total control over – and extract max profits from — this medicine that many millions of diabetics depend upon everyday and are unable to access. We go deep on how this insulin cartel is waging, as they write, “a war to remake insulin into a more profitable form, its patients into a more profitable demographic, and its market into a noncompetitive oligopoly.”